Daptomycin for methicillin-resistant Staphylococcus aureus infections of the spine

Spine Journal

Volumn 9, Issue 6, 2009, Pages e5-

  Burdette, Steven D ^a  

^a WRIGHT STATE UNIVERSITY   (United States)

Author keywords

Bacteremia; Daptomycin; Discitis; Epidural abscess; Lumbar subdural abscess; Methicillin resistant S. aureus; Osteomyelitis; Vancomycin

Indexed keywords

ANTIBIOTIC AGENT; BICALUTAMIDE; CEFTRIAXONE; CIPROFLOXACIN; COTRIMOXAZOLE; CREATINE KINASE; CREATININE; DAPTOMYCIN; DOXYCYCLINE; ERYTHROMYCIN; GENTAMICIN; LEVOFLOXACIN; OXACILLIN; PIPERACILLIN PLUS TAZOBACTAM; RIFAMPICIN; TETRACYCLINE; VANCOMYCIN;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; ATELECTASIS; BACKACHE; BACTEREMIA; BACTERIAL MENINGITIS; BACTERIUM CULTURE; BACTERIURIA; BLOOD CULTURE; BLOOD EXAMINATION; BLOOD PRESSURE; BODY TEMPERATURE; BONE MARROW DISEASE; BREATHING RATE; CASE REPORT; CEREBROSPINAL FLUID CULTURE; COMPUTER ASSISTED TOMOGRAPHY; CONVALESCENCE; CREATINE KINASE BLOOD LEVEL; CREATININE BLOOD LEVEL; DIASTOLIC DYSFUNCTION; DISKITIS; DRUG BLOOD LEVEL; DRUG DOSE REDUCTION; DRUG MEGADOSE; DRUG SUBSTITUTION; DRUG TOLERABILITY; DRUG WITHDRAWAL; ECHOCARDIOGRAPHY; EDEMA; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE INFECTION; EPIDURAL ABSCESS; ERYTHROCYTE SEDIMENTATION RATE; FEVER; FOLLOW UP; HEMIPELVECTOMY; HUMAN; HYDRATION; HYDRONEPHROSIS; INTRAVENOUS DRUG ABUSE; KIDNEY FAILURE; LAMINECTOMY; LETHARGY; LUMBAR PUNCTURE; LUMBAR SPINE; LUNG INFILTRATE; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSTRUCTIVE UROPATHY; OSTEOMYELITIS; PRIORITY JOURNAL; PROSTATE CANCER; PULSE RATE; SPINE DISEASE; SPONDYLITIS; SUBDURAL EMPYEMA; SYSTOLIC HEART MURMUR; THORACIC SPINE; THORAX PAIN; THORAX RADIOGRAPHY; URINALYSIS; WHEEZING;

EID: 67349125957     PISSN: 15299430     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.spinee.2008.11.008     Document Type: Article

References (15)

1. Centers for Disease Control and Prevention. MRSA among ICU patients, 1995-2004. Available at: http://www.cdc.gov/ncidod/dhqp/pdf/ar/ICU_RESTrend1995-2004.pdf. Accessed October 16, 2007.
2. Whitby M., McLaws M.L., and Berry G. Risk of death from methicillin-resistant Staphylococcus aureus bacteraemia: a meta-analysis. Med J Aust 175 (2001) 264-267
3. Cosgrove S.E., Sakoulas G., Perencevich E.N., Schwaber M.J., Karchmer A.W., and Carmeli Y. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis 36 (2003) 53-59
4. Shurland S., Zhan M., Bradham D.D., and Roghmann M.C. Comparison of mortality risk associated with bacteremia due to methicillin-resistant and methicillin-susceptible Staphylococcus aureus. Infect Control Hosp Epidemiol 28 (2007) 273-279
5. Wang G., Hindler J.F., Ward K.W., and Bruckner D.A. Increased vancomycin MICs for Staphylococcus aureus clinical isolates from a university hospital during a 5-year period. J Clin Microbiol 44 (2006) 3883-3886
6. Sakoulas G., Moise-Broder P.A., Schentag J., Forrest A., Moellering Jr. R.C., and Eliopoulos G.M. Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia. J Clin Microbiol 42 (2004) 2398-2402
7. Maclayton D.O., Suda K.J., Coval K.A., York C.B., and Garey K.W. Case-control study of the relationship between MRSA bacteremia with a vancomycin MIC of 2 microg/mL and risk factors, costs, and outcomes in inpatients undergoing hemodialysis. Clin Ther 28 (2006) 1208-1216
8. King A., and Phillips I. The in vitro activity of daptomycin against 514 Gram-positive aerobic clinical isolates. J Antimicrob Chemother 48 (2001) 219-223
9. Cubicin. [prescribing information] (2007), Cubist Pharmaceuticals, Lexington, MA
10. Lakey J.H., and Ptak M. Fluorescence indicates a calcium-dependent interaction between the lipopeptide antibiotic LY146032 and phospholipid membranes. Biochemistry 27 (1988) 4639-4645
11. Wu M., and Hancock R.E. Interaction of the cyclic antimicrobial cationic peptide bactenecin with the outer and cytoplasmic membrane. J Biol Chem 274 (1999) 29-35
12. Novo D., Perlmutter N.G., Hunt R.H., and Shapiro H.M. Accurate flow cytometric membrane potential measurement in bacteria using diethyloxacarbocyanine and a ratiometric technique. Cytometry 35 (1999) 55-63
13. Silverman J.A., Perlmutter N.G., and Shapiro H.M. Correlation of daptomycin bactericidal activity and membrane depolarization in Staphylococcus aureus. Antimicrob Agents Chemother 47 (2003) 2538-2544
14. Falagas M.E., Giannopoulou K.P., Ntziora F., and Papagelopoulos P.J. Daptomycin for treatment of patients with bone and joint infections: a systematic review of the clinical evidence. Int J Antimicrob Agents 30 (2007) 202-209
15. Gerber P., Stucki A., Acosta F., Cottagnoud M., and Cottagnoud P. Daptomycin is more efficacious than vancomycin against methicillin-susceptible Staphylococcus aureus in experimental meningitis. J Antimicrob Chemother 57 (2006) 720-723